Protagonist Therapeutics to Present at Investment Bank Conferences in September 2025
ByAinvest
Tuesday, Aug 26, 2025 4:16 pm ET1min read
PTGX--
At Citi's Biopharma Back to School Summit, scheduled for September 2-3 in Boston, MA, Patel will engage in a fireside chat on Wednesday, September 3, at 9:45 A.M. ET. The event will be webcast and available for replay on the company's Investor Relations webpage [1].
Patel will also participate in a fireside chat at H.C. Wainwright's 27th Annual Global Investment Conference, taking place from September 8-10 in New York, NY. This event will feature Patel's talk on Tuesday, September 9, at 11:30 A.M. ET, also with a webcast available for replay [1].
At BofA's 11th Annual World Medical Innovation Forum, held from September 15-17 in Boston, MA, Patel will join a panel discussion titled "Immunology: Creating the next blockbuster in I&I" on Tuesday, September 16 [1].
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company with two novel peptides in advanced Phase 3 clinical development. Icotrokinra, a first-in-class investigational targeted oral peptide, is licensed to J&J Innovative Medicines, and Rusfertide, a mimetic of the natural hormone hepcidin, is being co-developed with Takeda Pharmaceuticals for the rare blood disorder polycythemia vera (PV) [1].
Interested parties can reach out to their respective conference representatives to arrange meetings with the Protagonist team. Replays of the presentations will be available on the Company's Investor Relations Events and Presentations webpage for one year following the event [1].
References:
[1] https://www.newswire.com/news/protagonist-therapeutics-to-participate-in-multiple-investment-bank-conferences
Protagonist Therapeutics, a biopharmaceutical company, will participate in several investment bank conferences in September 2025. CEO Dinesh V. Patel will give fireside chats at Citi's Biopharma Back to School Summit, H.C. Wainwright's Global Investment Conference, and BofA's World Medical Innovation Forum. A replay of the presentations will be available on the company's website for one year.
Protagonist Therapeutics, Inc., a biopharmaceutical company, has announced its participation in several key investment bank conferences in September 2025. CEO Dinesh V. Patel, Ph.D., will be present at Citi's 2025 Biopharma Back to School Summit, H.C. Wainwright's 27th Annual Global Investment Conference, and BofA's 11th Annual World Medical Innovation Forum.At Citi's Biopharma Back to School Summit, scheduled for September 2-3 in Boston, MA, Patel will engage in a fireside chat on Wednesday, September 3, at 9:45 A.M. ET. The event will be webcast and available for replay on the company's Investor Relations webpage [1].
Patel will also participate in a fireside chat at H.C. Wainwright's 27th Annual Global Investment Conference, taking place from September 8-10 in New York, NY. This event will feature Patel's talk on Tuesday, September 9, at 11:30 A.M. ET, also with a webcast available for replay [1].
At BofA's 11th Annual World Medical Innovation Forum, held from September 15-17 in Boston, MA, Patel will join a panel discussion titled "Immunology: Creating the next blockbuster in I&I" on Tuesday, September 16 [1].
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company with two novel peptides in advanced Phase 3 clinical development. Icotrokinra, a first-in-class investigational targeted oral peptide, is licensed to J&J Innovative Medicines, and Rusfertide, a mimetic of the natural hormone hepcidin, is being co-developed with Takeda Pharmaceuticals for the rare blood disorder polycythemia vera (PV) [1].
Interested parties can reach out to their respective conference representatives to arrange meetings with the Protagonist team. Replays of the presentations will be available on the Company's Investor Relations Events and Presentations webpage for one year following the event [1].
References:
[1] https://www.newswire.com/news/protagonist-therapeutics-to-participate-in-multiple-investment-bank-conferences
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet